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The inclusion of novel small molecules in crystallization experiments has
provided very encouraging results and this method is now emerging as a
promising alternative strategy for crystallizing ‘problematic’ biological macro-
molecules. These small molecules have the ability to promote lattice formation
through stabilizing intermolecular interactions in protein crystals. Here, the use
of 1,3,6,8-pyrenetetrasulfonic acid (PTS), which provides a helpful intermole-
cular bridge between Leishmania mexicana PYK (LmPYK) macromolecules in
the crystal, is reported, resulting in the rapid formation of a more stable crystal
lattice at neutral pH and greatly improved X-ray diffraction results. The refined
structure of the LmPYK–PTS complex revealed the negatively charged PTS
molecule to be stacked between positively charged (surface-exposed) arginine
side chains from neighbouring LmPYK molecules in the crystal lattice.
1. Introduction
The inherent difficulty in crystallizing many biological macro-
molecules still requires innovative approaches. One such method is
the inclusion of small molecules in the crystallization conditions
which have the ability to promote lattice formation through stabi-
lizing intermolecular interactions in protein crystals. The success of
such a collection of small molecules has been demonstrated for quite
a few protein candidates (McPherson & Cudney, 2006) with various
methods of lattice stabilization (Larson et al., 2007), leading quickly
to their availability from Hampton Research (Silver Bullets). Here,
we report the use of the small molecule 1,3,6,8-pyrenetetrasulfonic
acid (PTS; Fig. 2d), which provides a helpful molecular link between
Leishmania mexicana PYK (LmPYK) macromolecules in the crystal
(similar to that seen for Silver Bullets; Larson et al., 2007), promoting
the rapid formation of a stable crystal lattice at neutral pH with
greatly improved X-ray diffraction results.
2. Materials and methods
2.1. Protein expression and purification
LmPYK was overexpressed and purified using a modified version
of the published protocol (Rigden et al., 1999), all purification steps
were performed at 281 K. Briefly, LmPYK samples were concen-
trated and buffer-exchanged (PD-10 column; Amersham Bio-
sciences) into buffer A [50 mM triethanolamine–HCl (TEA) buffer
pH 7.2, 20 mM KCl, 20% glycerol] using standard protocols. LmPYK
samples were loaded onto a (35 ml) DEAE Sepharose ion-exchange
column pre-equilibrated in buffer A at 0.5 ml min1. The column was
washed (3.0 ml min1) with ten column volumes of buffer A. LmPYK
was eluted over a five column-volume elution gradient (0–60%) with
buffer B (50 mM TEA buffer pH 7.2, 200 mM KCl, 20% glycerol).
Fractions containing LmPYK were pooled, concentrated and buffer-
exchanged into buffer C (20 mM TEA buffer pH 7.2, 20% glycerol).
LmPYK samples were concentrated to 30 mg ml1 and aliquots were
stored at 253 K for up to three months.
2.2. Crystallization and data collection
Purified LmPYK aliquots (30 mg ml1) were diluted to 15 mg ml1
using a buffer containing 20 mM triethanolamine–HCl pH 7.2 and
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1 mM PTS. Single crystals of LmPYK complexed with PTS were
obtained at 277 K by vapour diffusion using the hanging-drop tech-
nique. The drops were formed by mixing 1.5 ml protein solution with
1.5 ml well solution composed of 12–16% PEG 8000, 20 mM tri-
ethanolamine–HCl buffer pH 7.2, 50 mM MgCl2, 100 mM KCl and
10% glycerol. The drops were equilibrated against a reservoir filled
with 0.5 ml well solution. Crystals grew to maximum dimensions
(1.0  0.2  0.1 mm) after 24–48 h. Prior to data collection, crystals
were equilibrated for 14 h over a well solution composed of 14–18%
PEG 8000, 20 mM triethanolamine–HCl buffer pH 7.2, 50 mM
MgCl2, 100 mM KCl and 25% glycerol, which eliminated the
appearance of ice rings. Intensity data were collected (’ scans of 1
over 220) to a resolution of 2.1 A˚ from a single crystal flash-frozen
in liquid nitrogen at 100 K on beamline ID23-1 at the European
Synchrotron Radiation Facility (ESRF), Grenoble, France. Data were
processed with MOSFLM (Leslie, 2002) and scaled with SCALA
(Evans, 2006).
2.3. Structure determination
The structure of the LmPYK–PTS complex was solved by mole-
cular replacement using the program Phaser (McCoy et al., 2007). A
monomer from the previously determined tetrameric structure of
LmPYK (PDB code 1pkl; Rigden et al., 1999) was divided into two
search domains. Domain 1 (residues Pro87–Pro187, a complete B-
domain) and domain 2 (residues 1–86, 188–481 and 489–498) served
as search models. There was a clear molecular-replacement solution
with two monomers in the crystallographic asymmetric unit, with the
crystallographic twofold generating a tetramer. Only one of the
crystallographically independent B-domains had interpretable elec-
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Figure 1
Improvement of LmPYK crystal quality on crystallization in the presence of PTS. (a, b) Light-microscope photographs of LmPYK crystals in the presence (a) and absence
(b) of PTS. (c, d) A typical 1 oscillation image obtained during data collection from LmPYK crystals grown in the presence (c) and absence (d) of PTS. The edge of the
oscillation image corresponds to the blue circle and the maximum resolution of the image is shown in the bottom left corner.
tron density. The resulting model was then subjected to ten cycles of
rigid-body refinement using the program REFMAC (Murshudov et
al., 1997). The PTS molecule was added where clear unbiased Fo  Fc
electron density was observed and the model was then subjected to
several rounds of restrained refinement using tight geometrical
restraints; manual adjustments were made using Coot (Emsley &
Cowtan, 2004), resulting in R and Rfree values of 26% and 29%,
respectively. Water molecules were added to the model using Coot
and after several rounds of restrained refinement (using loose
geometrical restraints) the final model yielded R and Rfree values of
18.91% and 23.91%, respectively. The B-domain for which no clear
electron density was observed was modelled in an identical position
to that of the well defined B-domain and a final round of refinement
yielded R and Rfree values of 18.55% and 23.88%, respectively. All
atoms were modelled with full occupancy and with individual atomic
B factors. The geometry of the model was assessed using MolProbity
(Davis et al., 2007). Although electron density was well defined for
Thr296 (a key active-site residue), it exhibited geometry outside the
Ramachandran plot, which is common in many PYK structures. This
is primarily owing to a restricted geometry which facilitates inter-
structural communications
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Figure 2
Stabilization of the LmPYK crystal lattice as a result of cocrystallization with PTS. (a, b) Two orthogonal views of two LmPYK tetramers observed in the crystal lattice
stabilized by PTS (shown as spheres). The orientations of the LmPYK tetramers are shown as blocks and repetition of LmPYK in this PTS-stabilized manner forms the
crystal lattice (c). (d) A schematic drawing of a PTS molecule and the stacking interactions of Arg194 with pyrene. (e) A molecule of PTS lies at the interface between two
protein molecules (blue and green) in the LmPYK crystal. The PTS molecule is shown with electron density from a 2Fo  Fc map. The map was calculated at 2.1 A˚ and is
contoured at 1.
actions with active-site ligands. The coordinates of the LmPYK–PTS
complex have been deposited in the Protein Data Bank as entry 3ktx.
3. Results and discussion
LmPYK crystals grown in the presence of 0.25 mM PTS (Fig. 1a)
diffracted to a maximum resolution of 2.1 A˚ (Fig. 1c; see Table 1 for
data-collection and refinement statistics). LmPYK–PTS data were
indexed in the orthorhombic space group I222. There are two
monomers per asymmetric unit (ASU) and the biologically relevant
tetramer is generated by a crystallographic twofold rotation axis.
Ordered electron density was only observed for one of the two
B-domains, which is not uncommon in PYK structures (Valentini et
al., 2002; Wernimont et al., unpublished work) as this domain is highly
flexible (average B factor of 52 A˚2, with a range from 43 to 64 A˚2)
and as a result is often found in various orientations in PYK struc-
tures (Larsen et al., 1994; Valentini et al., 2002; Christofk et al., 2008).
For completion, the missing B-domain in chain B was modelled in an
identical position to that of chain A. Ordered electron density was not
observed for the effector loops (residues Ala481–Tyr488), which are
normally disordered when the effector molecule is unbound (Rigden
et al., 1999). Both chains were similar, with a root-mean-square
deviation of 0.15 A˚ for all C atoms of residues 1–498 and an r.m.s.d.
of 0.15 A˚ for all C atoms of residues 1–87 and 188–480 (excluding the
B-domains). The LmPYK–PTS tetramer was superimposed onto the
inactive LmPYK 1pkl (chains EFGH), resulting in an r.m.s. fit for all
C atoms of 0.72 A˚, indicating that the LmPYK–PTS structure was in
the inactive (T) conformation.
The incorporation of two PTS molecules within the crystal lattice,
at the junction between two crystallographically related LmPYK
tetramer molecules (Figs. 2a and 2b), allows tetramers to pack along
the crystallographic twofold screw axis, forming a PTS-stabilized
lattice (Fig. 2c). The two tetramers are drawn together by two PTS
molecules, which form a negatively charged bridge between two
positively charged arginine side chains (Fig. 2e). An important
feature of cocrystallizing LmPYK with PTS is the very significant
decrease in the time taken (from two weeks to 2 d) to grow high-
quality diffracting LmPYK crystals. The addition of PTS resulted in
the growth of large crystals within 24–48 h (Fig. 1a) which diffracted
to a greatly improved resolution of 2.1 A˚ (compare Figs. 1c and 1d,
with and without PTS). Sufficient data could not be obtained from
LmPYK crystals grown under similar conditions but in the absence of
PTS; therefore, a structural comparison of PYK in the presence and
absence of PTS could not be completed.
LmPYK (Rigden et al., 1999) and LmPYK Glu451Trp (Tulloch et
al., 2008) crystallized in the presence of ammonium sulfate under
acidic conditions (pH 4.0–4.6) resulted in structures with resolution
limits of 2.35 and 3.3 A˚, respectively. An additional complication
caused by crystallizing the allosteric enzyme using ammonium sulfate
was the tendency for sulfate ions to compete with the binding of the
natural phosphometabolites (adenosine triphosphate, fructose-2,6-
bisphosphate and phosphoenolpyruvate) and active-site and effector-
site ligands (Tulloch et al., 2008). The low pH required for the
crystallization of LmPYK also presented problems concerning the
charged states of amino acids and the subsequent effect upon the
conformational state observed in the crystal structures. LmPYK
(apo) was crystallized at a more neutral pH (7.3–8.5) using PEG 4000
as the major precipitant (Rigden et al., 1999). However, these crystals
(Fig. 1b) were difficult to obtain and only diffracted to a maximum
resolution of between 3.4 and 3.5 A˚ (Fig. 1d). PTS provides a useful
crosslink between LmPYK macromolecules in the crystal, forming a
stable crystal lattice at a neutral pH with greatly improved X-ray
diffraction results. The novel properties of PTS as a crystallization
additive have been further exploited in the successful determination
of structures of LmPYK in complex with various lead inhibitors.
Refinement of these structures is currently in progress and will be
published at a later date.
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Table 1
Data-collection and refinement statistics.
Values in parentheses are for the outer shell.
Data collection
Space group I222
Unit-cell parameters (A˚) a = 122, b = 130, c = 165
Wavelength (A˚) 1.0
Resolution (A˚) 2.1
No. of reflections 696295
No. of unique reflections 76957
Rmerge (%) 7.60 (52.70)
Rmeas (%) 8.00 (56.10)
Rp.i.m. (%) 2.70 (18.90)
I/(I) 20.10 (4.20)
Completeness (%) 99.90 (100.00)
Refinement
Resolution range 20.69–2.10
No. of reflections in working set 73091
No. of reflections in test set 3865
Rcryst (%) 18.55
Rfree (%) 23.88
Average B factor (protein) (A˚2) 44.68
No. of protein atoms 7506
No. of water molecules 639
R.m.s.d. from ideal geometry
Bond lengths (A˚) 0.02
Bond angles () 1.82
Ramachandran plot
Allowed (%) 98.20 [958/976]
Generously allowed (%) 99.80 [974/976]
Disallowed (%) 0.20 [2/976]
